Population pharmacokinetics of artesunate and amodiaquine in African children
-
* Corresponding author: Kasia Stepniewska kasia@tropmedres.ac
Malaria Journal 2009, 8:200 doi:10.1186/1475-2875-8-200
Accesses
- Last 30 days: 81 accesses
- Last year: 1075 accesses
- All time: 4258 accesses
Cited by
BioMed Central: 3 citations
|
Carrie A Morris, Stephan Duparc, Isabelle Borghini-Fuhrer, Donald Jung, Chang-Sik Shin, Lawrence Fleckenstein Malaria Journal 2011, 10:263 (13 September 2011) This paper gives a detailed review of the pharmacokinetic properties of artesunate, and its active metabolite dihydroartemisinin, following all routes of administration.
|
|
Kris M Jamsen, Stephen B Duffull, Joel Tarning, Niklas Lindegardh, Nicholas J White, Julie A Simpson Malaria Journal 2011, 10:181 (1 July 2011) This article presents a novel and successful attempt to rationalize the sampling schedules for PK studies of anti-malarials given unavoidable practical constraints. It provides a practical guide to those designing population PK studies specifically of oral artesunate, and a "proof of principle" for applying optimal design methodology for anti-malarials in general.
|
|
Beesan Tan, Himanshu Naik, In-Jin Jang, Kyung-Sang Yu, Lee E Kirsch, Chang-Sik Shin, J Craft, Lawrence Fleckenstein Malaria Journal 2009, 8:304 (18 December 2009) Using pooled data from four phase I clinical studies (healthy subjects), this paper determines the population pharmacokinetics of artesunate and dihydroartemisinin using a parent-metabolite model and simultaneously modelling the drug concentrations of artesunate and DHA.
|